Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 1
1990 3
1992 1
1994 3
1995 12
1996 7
1997 7
1998 8
1999 3
2000 1
2001 2
2002 3
2003 1
2004 5
2005 5
2006 4
2007 8
2008 8
2009 12
2010 15
2011 8
2012 11
2013 12
2014 15
2015 23
2016 17
2017 15
2018 18
2019 15
2020 19
2021 13
2022 16
2023 10
2024 8
2025 7

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

50 results

Results by year

Filters applied: in the last 5 years, Clinical Trial, Randomized Controlled Trial. Clear all
Page 1
Resistant starch decreases intrahepatic triglycerides in patients with NAFLD via gut microbiome alterations.
Ni Y, Qian L, Siliceo SL, Long X, Nychas E, Liu Y, Ismaiah MJ, Leung H, Zhang L, Gao Q, Wu Q, Zhang Y, Jia X, Liu S, Yuan R, Zhou L, Wang X, Li Q, Zhao Y, El-Nezami H, Xu A, Xu G, Li H, Panagiotou G, Jia W. Ni Y, et al. Cell Metab. 2023 Sep 5;35(9):1530-1547.e8. doi: 10.1016/j.cmet.2023.08.002. Cell Metab. 2023. PMID: 37673036 Free article. Clinical Trial.
Non-alcoholic fatty liver disease (NAFLD) is a hepatic manifestation of metabolic dysfunction for which effective interventions are lacking. To investigate the effects of resistant starch (RS) as a microbiota-directed dietary supplement for NAFLD treatment, we coupl …
Non-alcoholic fatty liver disease (NAFLD) is a hepatic manifestation of metabolic dysfunction for which effective interventions are lacking. …
Resistant starch intake facilitates weight loss in humans by reshaping the gut microbiota.
Li H, Zhang L, Li J, Wu Q, Qian L, He J, Ni Y, Kovatcheva-Datchary P, Yuan R, Liu S, Shen L, Zhang M, Sheng B, Li P, Kang K, Wu L, Fang Q, Long X, Wang X, Li Y, Ye Y, Ye J, Bao Y, Zhao Y, Xu G, Liu X, Panagiotou G, Xu A, Jia W. Li H, et al. Nat Metab. 2024 Mar;6(3):578-597. doi: 10.1038/s42255-024-00988-y. Epub 2024 Feb 26. Nat Metab. 2024. PMID: 38409604 Free PMC article. Clinical Trial.
In a randomized placebo-controlled crossover design trial (ChiCTR-TTRCC-13003333) in 37 participants with overweight or obesity, we test whether resistant starch (RS) as a dietary supplement influences obesity-related outcomes. Here, we show that RS supplementation …
In a randomized placebo-controlled crossover design trial (ChiCTR-TTRCC-13003333) in 37 participants with overweight or obesity, we test whe …
CAPP2 RCT: Resistant Starch Planned Long-term Follow-up-Reply.
Mathers JC, Elliott F, Bishop DT, Burn J. Mathers JC, et al. Cancer Prev Res (Phila). 2023 Jan 4;16(1):59. doi: 10.1158/1940-6207.CAPR-22-0476. Cancer Prev Res (Phila). 2023. PMID: 36597730 Clinical Trial. No abstract available.
Type 3 resistant starch from Canna edulis reduce lipid levels in patients with mild hyperlipidemia through altering gut microbiome: A double- blind randomized controlled trial.
Miao T, Zhang X, Zhang C, Wu J, Zhu Y, Xiao M, Zhang N, Zhong Y, Liu Y, Lin Y, Wu Y, Li W, Song C, Liu Y, Wang X. Miao T, et al. Pharmacol Res. 2024 Jul;205:107232. doi: 10.1016/j.phrs.2024.107232. Epub 2024 May 31. Pharmacol Res. 2024. PMID: 38825157 Free article. Clinical Trial.
Type 3 resistant starch from Canna edulis (Ce-RS3) is an insoluble dietary fiber which could improve blood lipids in animals, but clinically robust evidence is still lacking. ...Clinical study on anti-mild hyperlipidemia of Canna edulis RS3 resistant starc …
Type 3 resistant starch from Canna edulis (Ce-RS3) is an insoluble dietary fiber which could improve blood lipids in animals, …
Impact of resistant starch type 3 on fecal microbiota and stool frequency in Thai adults with chronic constipation randomized clinical trial.
Luk-In S, Leepiyasakulchai C, Saelee C, Keeratichamroen A, Srisangwan N, Ponprachanuvut P, Chammari K, Chatsuwan T, Wannigama DL, Shein AMS, Kueakulpattana N, Srisakul S, Sranacharoenpong K. Luk-In S, et al. Sci Rep. 2024 Nov 14;14(1):27944. doi: 10.1038/s41598-024-79465-1. Sci Rep. 2024. PMID: 39543201 Free PMC article. Clinical Trial.
While the impacts of numerous probiotics on constipation are well-characterized, there has been limited assessment of the potential prebiotic effects of resistant starches. We therefore conducted a randomized, double-blind and placebo-controlled, clinical trial of resis …
While the impacts of numerous probiotics on constipation are well-characterized, there has been limited assessment of the potential prebioti …
Resistant starch wheat increases PYY and decreases GIP but has no effect on self-reported perceptions of satiety.
Hughes RL, Horn WF, Wen A, Rust B, Woodhouse LR, Newman JW, Keim NL. Hughes RL, et al. Appetite. 2022 Jan 1;168:105802. doi: 10.1016/j.appet.2021.105802. Epub 2021 Nov 10. Appetite. 2022. PMID: 34774669 Free article. Clinical Trial.
This double-blind, randomized, placebo-controlled, crossover study investigated the effects of resistant starch type 2 (RS2) from wheat on self-reported perceptions of satiety and associated gut hormones in 30 healthy adults ages 40-65 years of age. ...
This double-blind, randomized, placebo-controlled, crossover study investigated the effects of resistant starch type 2 (RS2) f …
Faecal microbial transfer and complex carbohydrates mediate protection against COPD.
Budden KF, Shukla SD, Bowerman KL, Vaughan A, Gellatly SL, Wood DLA, Lachner N, Idrees S, Rehman SF, Faiz A, Patel VK, Donovan C, Alemao CA, Shen S, Amorim N, Majumder R, Vanka KS, Mason J, Haw TJ, Tillet B, Fricker M, Keely S, Hansbro N, Belz GT, Horvat J, Ashhurst T, van Vreden C, McGuire H, Fazekas de St Groth B, King NJC, Crossett B, Cordwell SJ, Bonaguro L, Schultze JL, Hamilton-Williams EE, Mann E, Forster SC, Cooper MA, Segal LN, Chotirmall SH, Collins P, Bowman R, Fong KM, Yang IA, Wark PAB, Dennis PG, Hugenholtz P, Hansbro PM. Budden KF, et al. Gut. 2024 Apr 5;73(5):751-769. doi: 10.1136/gutjnl-2023-330521. Gut. 2024. PMID: 38331563 Clinical Trial.
Complex carbohydrates were assessed in mice using a high resistant starch diet, and in 16 patients with COPD using a randomised, double-blind, placebo-controlled pilot study of inulin supplementation. ...Proteomics and metabolomics identified downregulation of gluco …
Complex carbohydrates were assessed in mice using a high resistant starch diet, and in 16 patients with COPD using a randomise …
Resistant Starch Type-2 Supplementation Does Not Decrease Trimethylamine N-Oxide (TMAO) Plasma Level in Hemodialysis Patients.
Kemp JA, Dos Santos HF, de Jesus HE, Esgalhado M, de Paiva BR, Azevedo R, Stenvinkel P, Bergman P, Lindholm B, Ribeiro-Alves M, Mafra D. Kemp JA, et al. J Am Nutr Assoc. 2022 Nov-Dec;41(8):788-795. doi: 10.1080/07315724.2021.1967814. Epub 2022 Feb 15. J Am Nutr Assoc. 2022. PMID: 35512757 Clinical Trial.
This study aimed to evaluate the effect of amylose-resistant starch (RS) supplementation on TMAO plasma levels in HD patients. We conducted a randomized, double-blind, placebo-controlled trial (NCT02706808) with patients undergoing HD enrolled in a previous pilot st …
This study aimed to evaluate the effect of amylose-resistant starch (RS) supplementation on TMAO plasma levels in HD patients. …
Effects of resistant starch on glycemic response, postprandial lipemia and appetite in subjects with type 2 diabetes.
García-Vázquez C, Ble-Castillo JL, Arias-Córdova Y, Ramos-García M, Olvera-Hernández V, Guzmán-Priego CG, Martínez-López MC, Jiménez-Domínguez G, Hernández-Becerra JA. García-Vázquez C, et al. Eur J Nutr. 2023 Aug;62(5):2269-2278. doi: 10.1007/s00394-023-03154-4. Epub 2023 Apr 21. Eur J Nutr. 2023. PMID: 37083722 Clinical Trial.
PURPOSE: Resistant starch (RS) content has exhibited beneficial effects on glycemic control; however, few studies have investigated the effects of this substance on postprandial responses and appetite in subjects with type 2 diabetes (T2D). ...METHODS: In a randomiz …
PURPOSE: Resistant starch (RS) content has exhibited beneficial effects on glycemic control; however, few studies have investi …
Resistant Starch Consumption Effects on Glycemic Control and Glycemic Variability in Patients with Type 2 Diabetes: A Randomized Crossover Study.
Arias-Córdova Y, Ble-Castillo JL, García-Vázquez C, Olvera-Hernández V, Ramos-García M, Navarrete-Cortes A, Jiménez-Domínguez G, Juárez-Rojop IE, Tovilla-Zárate CA, Martínez-López MC, Méndez JD. Arias-Córdova Y, et al. Nutrients. 2021 Nov 12;13(11):4052. doi: 10.3390/nu13114052. Nutrients. 2021. PMID: 34836304 Free PMC article. Clinical Trial.
We previously observed beneficial effects of native banana starch (NBS) with a high resistant starch (RS) content on glycemic response in lean and obese participants. Here, we aimed to determine the effects of NBS and high-amylose maize starch (HMS) on …
We previously observed beneficial effects of native banana starch (NBS) with a high resistant starch (RS) content on gl …
50 results